34 companies

Shanghai Allist Pharmaceuticals

Market Cap: CN¥47.5b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.

688578

CN¥101.88

7D

-10.8%

1Y

89.3%

Imeik Technology DevelopmentLtd

Market Cap: CN¥47.4b

Engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China.

300896

CN¥151.92

7D

-7.1%

1Y

-31.6%

Chengdu Kanghong Pharmaceutical Group

Market Cap: CN¥30.5b

Research, develops, manufactures, and distributes medicine for ophthalmic, neuropsychiatric and other applications in China.

002773

CN¥30.87

7D

-4.8%

1Y

59.7%

Hanmi Pharm

Market Cap: ₩5.4t

A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.

New

A128940

₩449,000.00

7D

10.7%

1Y

33.4%

Jamjoom Pharmaceuticals Factory

Market Cap: ر.س10.9b

Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.

4015

ر.س155.00

7D

1.1%

1Y

-5.1%

BioArctic

Market Cap: SEK 25.0b

Develops biological drugs for patients with central nervous system disorders in Sweden.

BIOA B

SEK 282.20

7D

-4.1%

1Y

96.7%

Anhui Anke Biotechnology (Group)

Market Cap: CN¥18.2b

Anhui Anke Biotechnology (Group) Co., Ltd.

New

300009

CN¥10.84

7D

6.0%

1Y

15.9%

Aurinia Pharmaceuticals

Market Cap: US$1.7b

A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.

New

AUPH

US$13.17

7D

7.2%

1Y

82.7%

Neuren Pharmaceuticals

Market Cap: AU$2.6b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

NEU

AU$20.69

7D

-3.3%

1Y

68.6%

Changzhou Qianhong BiopharmaLTD

Market Cap: CN¥11.6b

Manufactures and distributes polysaccharide and protease drugs in China.

New

002550

CN¥9.02

7D

1.2%

1Y

41.4%

Soho Global Health

Market Cap: Rp25.9t

Together with its subsidiaires, operates as a healthcare company in Indonesia.

SOHO

Rp2,040.00

7D

0%

1Y

195.7%

Bonesupport Holding

Market Cap: SEK 13.9b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

BONEX

SEK 211.20

7D

-9.0%

1Y

-35.9%

Indegene

Market Cap: ₹128.7b

Operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally.

New

INDGN

₹539.05

7D

-1.6%

1Y

-18.7%

BioGaia

Market Cap: SEK 10.2b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

BIOG B

SEK 100.60

7D

-3.1%

1Y

-7.2%

Zhejiang Yatai Pharmaceutical

Market Cap: CN¥6.5b

Researches, produces, sells, and exports pharmaceutical products in China and internationally.

002370

CN¥9.06

7D

27.2%

1Y

174.5%

Sunmax Biotechnology

Market Cap: NT$21.5b

A biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China.

4728

NT$393.00

7D

-1.3%

1Y

41.9%

Tibet Weixinkang Medicine

Market Cap: CN¥4.9b

Engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China.

603676

CN¥11.12

7D

-6.1%

1Y

9.4%

Zentiva

Market Cap: RON 3.2b

Engages in the production and marketing of preparations and medicines for human use in Romania and internationally.

SCD

RON 4.52

7D

0%

1Y

55.9%

Handa Pharmaceuticals

Market Cap: NT$18.7b

A specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States.

6620

NT$120.50

7D

-9.1%

1Y

93.7%

Niagen Bioscience

Market Cap: US$602.6m

Operates as a bioscience company engages in developing healthy aging products.

New

NAGE

US$7.23

7D

-4.9%

1Y

26.0%

Ever Supreme Bio Technology

Market Cap: NT$14.1b

Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.

6712

NT$162.00

7D

-0.6%

1Y

-1.8%

RPG Life Sciences

Market Cap: ₹40.4b

An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.

RPGLIFE

₹2,462.60

7D

3.6%

1Y

-6.5%

GlaxoSmithKline Pakistan

Market Cap: PK₨127.5b

Operates as a biopharma company in Pakistan.

GLAXO

PK₨400.31

7D

0.2%

1Y

37.3%

Novartis India

Market Cap: ₹21.6b

Novartis India Limited is involved in the pharmaceutical business in India.

New

500672

₹858.05

7D

-0.6%

1Y

-20.2%

Savior Lifetec

Market Cap: NT$5.4b

A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.

4167

NT$16.70

7D

-2.1%

1Y

-22.7%

Jagsonpal Pharmaceuticals

Market Cap: ₹15.1b

Engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.

New

JAGSNPHARM

₹216.61

7D

-2.7%

1Y

-9.7%

Genovis AB (publ.)

Market Cap: SEK 1.5b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

GENO

SEK 22.65

7D

-2.4%

1Y

3.4%

Quality Chemical Industries

Market Cap: USh423.1b

Manufactures and sells pharmaceutical drugs in Uganda.

QCIL

USh115.87

7D

0.8%

1Y

110.7%

Jenburkt Pharmaceuticals

Market Cap: ₹5.6b

Researches and develops, manufactures, and markets pharmaceutical and healthcare products in India.

New

524731

₹1,262.15

7D

18.4%

1Y

16.1%

G.F.C Green Fields Capital

Market Cap: ₪137.4m

Does not have significant operations.

GFC-M

₪13.69

7D

0.4%

1Y

19.0%

Cryosite

Market Cap: AU$58.6m

Provides outsourced clinical trials logistic services in Australia.

CTE

AU$1.19

7D

-8.5%

1Y

25.3%

Alpa Laboratories

Market Cap: ₹1.9b

Engages in the manufacture and sale of drugs and chemicals in India.

ALPA

₹89.26

7D

-0.08%

1Y

-20.0%

Par Drugs and Chemicals

Market Cap: ₹1.3b

Develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India.

PAR

₹99.15

7D

-1.6%

1Y

-67.2%

Amwill Health Care

Market Cap: ₹1.1b

A derma-cosmetic company, engages in the development and contract manufacturing of generic dermatological solutions in India.

544353

₹55.83

7D

4.1%

1Y

n/a